BioClinica
announced it has created strategic partnerships with two privately held clinical research organizations (CROs),
Axio Research Corporation
and
Beardsworth Consulting Group, Inc.
Both alliances strengthen the
BioClinica Certified Partner Program
and provide customers with additional support in complex therapeutic areas of study and data monitoring and management.
Mark Weinstein, CEO of BioClinica, Inc. "Both Axio Research and Beardsworth match the quality and industry leadership of all partners recognized by the BioClinica Certified Partner Program, and we are pleased to offer our customers this expanded support. Our certified partners now represent a collective experience of over 1000 trials in more than 6000 sites across 52 countries."
Since 1979, Axio Research has provided data management, statistical and medical writing services for industry, government, and academic sponsors in the clinical research field. Based in Seattle, Washington, the company also provides clinical trial design and clinical events committee support services, and serves as the independent statistical center for Data Monitoring Committees.
Based in Flemington, New Jersey, Beardsworth is a specialty CRO in Oncology, delivering a broad range of clinical research services to pharmaceutical and biotechnology companies. Since 1986, the company has focused on complicated trials in complex therapeutic areas, utilizing an internal paper-based data management system.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.